Speaker(s): 

Tara Avery, MD, Resident, Geisinger - has nothing to disclose.

Michael Woodfin, MD, Resident, Geisinger- has nothing to disclose.

Arjun Pandya, MD, Resident, Geisinger - has nothing to disclose.

M. Blake Richardson, MD, Resident, Geisinger- has nothing to disclose.

Adam Hetzler, MD, Resident, Geisinger- has nothing to disclose. 

Eric Hossler, MD, (Speaker/Moderator) Staff Member, Geisinger - has nothing to disclose.

Christen Mowad, MD (Speaker/Moderator) Staff Member, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  • Expand and review treatment options for benign and malignant skin cancer.
  • Improve clinicopathologic correlation.
  • Improve outcomes for patients with pediatric dermatologic conditions. 
  • Diagnose Seborrheic Keratosis in a clinical setting.
  • Discuss Ocular Manifestations of dermatologic diseases.
  • Identify and diagnose severe dermatologic conditions during patient viewing
  • Identify and diagnose severe dermatologic conditions during inpatient stays

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Eric W. Hossler, MD and Ashley Hubal, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None 

Session date: 
11/13/2024 - 8:00am to 1:00pm EST
Location: 
Dermatology Woodbine
Danville, PA
United States
  • 5.00 AAPA Category I CME
  • 5.00 AMA PRA Category 1 Credit
  • 5.00 Participation Credit

Please login or register to take this course.